Treatment for Pancreatic Cancer: Current Therapy and Continued Progress
Open Access
- 1 May 2005
- journal article
- review article
- Published by Elsevier in Gastroenterology
- Vol. 128 (6) , 1642-1654
- https://doi.org/10.1053/j.gastro.2005.03.039
Abstract
No abstract availableKeywords
This publication has 88 references indexed in Scilit:
- A Randomized Trial of Chemoradiotherapy and Chemotherapy after Resection of Pancreatic CancerNew England Journal of Medicine, 2004
- Adjuvant Therapy for Pancreatic Cancer — The Debate ContinuesNew England Journal of Medicine, 2004
- Gemcitabine-based therapy in pancreas cancerCancer, 2002
- The pemetrexed/gemcitabine combination in pancreatic cancerCancer, 2002
- Gemcitabine Combined With Oxaliplatin in Advanced Pancreatic Adenocarcinoma: Final Results of a GERCOR Multicenter Phase II StudyJournal of Clinical Oncology, 2002
- A phase II study: docetaxel as first-line chemotherapy for advanced pancreatic adenocarcinomaEuropean Journal Of Cancer, 2000
- A Phase II Study of Gemcitabine and 5-Fluorouracil in Metastatic Pancreatic Cancer: An Eastern Cooperative Oncology Group Study (E3296)Oncology, 2000
- Chemotherapy prolongs survival in inoperable pancreatic carcinomaBritish Journal of Surgery, 1994
- Activity of cisplatin in adenocarcinoma of the pancreasEuropean Journal Of Cancer, 1993
- Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of vater—results of a controlled, prospective, randomised multicentre studyEuropean Journal Of Cancer, 1993